Kangyu Lin

2.8k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Kangyu Lin is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Kangyu Lin has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Kangyu Lin's work include Cancer-related molecular mechanisms research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Kangyu Lin is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Kangyu Lin collaborates with scholars based in United States, China and Canada. Kangyu Lin's co-authors include Aidong Zhou, Sicong Zhang, Suyun Huang, Yaohui Chen, Keping Xie, Sadhan Majumder, Oliver Bögler, Erik P. Sulman, Zhike Lu and Chuan He and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kangyu Lin

22 papers receiving 2.1k citations

Hit Papers

m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glio... 2017 2026 2020 2023 2017 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kangyu Lin United States 13 1.9k 1.0k 263 181 126 26 2.1k
Zeyou Wang China 21 994 0.5× 835 0.8× 87 0.3× 39 0.2× 96 0.8× 38 1.3k
Jinlong Tang China 17 699 0.4× 572 0.5× 191 0.7× 25 0.1× 194 1.5× 47 1.2k
Cristel V. Camacho United States 14 952 0.5× 293 0.3× 575 2.2× 37 0.2× 81 0.6× 21 1.3k
Yongjie Ma China 17 764 0.4× 300 0.3× 163 0.6× 41 0.2× 76 0.6× 42 1.0k
Tiansuo Zhao China 24 643 0.3× 510 0.5× 677 2.6× 35 0.2× 413 3.3× 50 1.5k
Xiefeng Wang China 23 1.4k 0.7× 1.2k 1.2× 155 0.6× 12 0.1× 118 0.9× 45 1.8k
Sameer Mirza United States 23 1.1k 0.6× 393 0.4× 553 2.1× 14 0.1× 85 0.7× 54 1.6k
Eva Schut Netherlands 13 879 0.5× 228 0.2× 707 2.7× 32 0.2× 201 1.6× 15 1.3k
Jae‐Seok Roe South Korea 22 1.6k 0.9× 479 0.5× 376 1.4× 10 0.1× 249 2.0× 45 2.1k
Andrea M. Griesinger United States 17 759 0.4× 196 0.2× 300 1.1× 21 0.1× 224 1.8× 37 1.3k

Countries citing papers authored by Kangyu Lin

Since Specialization
Citations

This map shows the geographic impact of Kangyu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangyu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangyu Lin more than expected).

Fields of papers citing papers by Kangyu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangyu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangyu Lin. The network helps show where Kangyu Lin may publish in the future.

Co-authorship network of co-authors of Kangyu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Kangyu Lin. A scholar is included among the top collaborators of Kangyu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangyu Lin. Kangyu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciombor, Kristen K., Jennifer G. Whisenant, Gregory D. Ayers, et al.. (2025). Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer. Clinical Cancer Research. 31(8). 1437–1448. 6 indexed citations
2.
Morris, Van K., Suyu Liu, Kangyu Lin, et al.. (2025). Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal. Clinical Cancer Research. 31(9). 1657–1666. 1 indexed citations
3.
Shroff, Rachna T., Van K. Morris, Kangyu Lin, & Pamela L. Kunz. (2024). Evaluating speaker gender in scientific sessions at ASCO and ASCO GI (2019-2023).. Journal of Clinical Oncology. 42(16_suppl). 9009–9009.
4.
Morris, Van K., Weihong Xiao, Emma B. Holliday, et al.. (2024). Time dependency for HPV ctDNA detection as a prognostic biomarker for anal cancer.. Journal of Clinical Oncology. 42(16_suppl). 3513–3513. 3 indexed citations
5.
Lin, Kangyu & Toshiyuki Ohtsuka. (2024). A Gap Penalty Method for Optimal Control of Linear Complementarity Systems. 880–887.
6.
Wong, Chi Wut, Rosalba Minelli, Michael Peoples, et al.. (2024). Abstract 3280: ASCL2+ tumor cells modulate the response of colorectal cancer to MAPK targeting therapy. Cancer Research. 84(6_Supplement). 3280–3280.
7.
Lin, Kangyu, Saikat Chowdhury, Mohammad A. Zeineddine, et al.. (2023). Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing. Molecular Cancer Research. 22(4). 337–346. 8 indexed citations
8.
Chowdhury, Saikat, Joshua Millstein, Kangyu Lin, et al.. (2023). Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Colorectal Cancer. JCO Precision Oncology. 7(7). e2200422–e2200422. 3 indexed citations
9.
Zheng, Caishang, Yanjun Wei, Peng Zhang, et al.. (2023). CRISPR/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer. Journal of Clinical Investigation. 133(5). 25 indexed citations
10.
Hsu, Wen‐Hao, Kyle A. LaBella, Yiyun Lin, et al.. (2023). Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression. Cancer Discovery. 13(12). 2652–2673. 58 indexed citations
11.
Lin, Kangyu, Mohammad A. Zeineddine, Saikat Chowdhury, et al.. (2023). Abstract 2454: Identification of colorectal cancer stem cells from single cell RNA sequencing. Cancer Research. 83(7_Supplement). 2454–2454. 1 indexed citations
12.
Zhou, Aidong, Kangyu Lin, Sicong Zhang, et al.. (2017). Gli1‐induced deubiquitinase USP 48 aids glioblastoma tumorigenesis by stabilizing Gli1. EMBO Reports. 18(8). 1318–1330. 66 indexed citations
13.
Zhang, Sicong, Boxuan Zhao, Aidong Zhou, et al.. (2017). m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell. 31(4). 591–606.e6. 1146 indexed citations breakdown →
14.
Xue, Jianfei, Aidong Zhou, Yamei Wu, et al.. (2016). miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. Cancer Research. 76(14). 4293–4304. 76 indexed citations
15.
Chen, Yaohui, Li Yu, Jianfei Xue, et al.. (2016). Wnt‐induced deubiquitination FoxM1 ensures nucleus β‐catenin transactivation. The EMBO Journal. 35(6). 668–684. 90 indexed citations
16.
Zhou, Aidong, Kangyu Lin, Sicong Zhang, et al.. (2016). Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22. Nature Cell Biology. 18(9). 954–966. 134 indexed citations
17.
Shi, Peijie, et al.. (2016). Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia. Journal of Hematology & Oncology. 9(1). 12–12. 11 indexed citations
18.
Zeng, Chengwu, Zhenhua Chen, Xingju Zhang, et al.. (2014). MIR125B1represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. Autophagy. 10(10). 1726–1737. 43 indexed citations
20.
Zeng, Chengwu, Xingju Zhang, Kangyu Lin, et al.. (2012). Camptothecin Induces Apoptosis in Cancer Cells via MicroRNA-125b-Mediated Mitochondrial Pathways. Molecular Pharmacology. 81(4). 578–586. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026